Clonal Hematopoiesis and Risk of Stroke: Evidence From Over 800 000 Individuals Across 3 Cohorts | Synapse
April 10, 2026
Clonal Hematopoiesis and Risk of Stroke: Evidence From Over 800 000 Individuals Across 3 Cohorts
Puntos clave
The study aims to determine the association between clonal hematopoiesis and stroke risk and explore underlying inflammatory pathways.
Large-scale multicohort design
Analysis of over 800,000 individuals
Assessment of inflammatory markers and stroke incidence
Focus on interleukin-1-mediated pathways
Establishment of clonal hematopoiesis as a significant risk factor for stroke
Identification of interleukin-1-mediated inflammation as a potential therapeutic target
Quantitative correlation between clonal hematopoiesis and increased incidence of stroke
Resumen
Our large-scale, multicohort study establishes CHIP as a determinant of incident stroke risk and IL (interleukin)-1-mediated inflammation as a targetable pathway to reduce this risk.